<VariationArchive VariationID="191580" VariationName="NM_000432.4(MYL2):c.431del (p.Pro144fs)" VariationType="Deletion" Accession="VCV000191580" Version="13" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2018-04-16" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="189893" VariationID="191580">
      <GeneList>
        <Gene Symbol="MYL2" FullName="myosin light chain 2" GeneID="4633" HGNC_ID="HGNC:7583" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="110910845" stop="110921449" display_start="110910845" display_stop="110921449" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="111348622" stop="111358403" display_start="111348622" display_stop="111358403" Strand="-" />
          </Location>
          <OMIM>160781</OMIM>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000432.4(MYL2):c.431del (p.Pro144fs)</Name>
      <CanonicalSPDI>NC_000012.12:110911146:GGGGGG:GGGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="110911147" stop="110911147" display_start="110911147" display_stop="110911147" variantLength="1" positionVCF="110911146" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="111348951" stop="111348951" display_start="111348951" display_stop="111348951" variantLength="1" positionVCF="111348950" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="NCBI36" AssemblyAccessionVersion="GCF_000001405.12" AssemblyStatus="previous" Chr="12" Accession="NC_000012.10" start="109833339" stop="109833339" display_start="109833339" display_stop="109833339" variantLength="1" referenceAllele="G" alternateAllele="-" />
      </Location>
      <OtherNameList>
        <Name>1-BP DEL, 431C</Name>
      </OtherNameList>
      <ProteinChange>P144fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.111348956del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.111348956del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.110911152del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.110911152del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007554.1" sequenceAccession="NG_007554" sequenceVersion="1" change="g.14431del">
            <Expression>NG_007554.1:g.14431del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000432.4" sequenceAccession="NM_000432" sequenceVersion="4" change="c.431del" MANESelect="true">
            <Expression>NM_000432.4:c.431del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000423.2" sequenceAccession="NP_000423" sequenceVersion="2" change="p.Pro144fs">
            <Expression>NP_000423.2:p.Pro144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000432.4" sequenceAccession="NM_000432" sequenceVersion="4" change="c.431delC" MANESelect="true">
            <Expression>NM_000432.4:c.431delC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_393" sequenceAccession="LRG_393">
            <Expression>LRG_393:g.14431del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000432.3" sequenceAccession="NM_000432" sequenceVersion="3" change="c.431delC">
            <Expression>NM_000432.3:c.431delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA010340" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="160781.0007" DB="OMIM" />
        <XRef Type="rs" ID="786205430" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000432.4(MYL2):c.431del (p.Pro144fs) AND Hypertrophic cardiomyopathy" Accession="RCV000171842" Version="3">
        <ClassifiedConditionList TraitSetID="17368">
          <ClassifiedCondition DB="MedGen" ID="C0007194">Hypertrophic cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-04-05" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431del (p.Pro144fs) AND Cardiovascular phenotype" Accession="RCV000618518" Version="4">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-01" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431del (p.Pro144fs) AND Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy" Accession="RCV001553792" Version="1">
        <ClassifiedConditionList TraitSetID="69132">
          <ClassifiedCondition DB="MedGen" ID="C5561937">Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-08-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431del (p.Pro144fs) AND Hypertrophic cardiomyopathy 10" Accession="RCV001852081" Version="5">
        <ClassifiedConditionList TraitSetID="3886">
          <ClassifiedCondition DB="MedGen" ID="C1834460">Hypertrophic cardiomyopathy 10</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-24" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-24" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-16" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">23365102</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23861362</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28855170</ID>
        </Citation>
        <DescriptionHistory Dated="2023-04-12">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-08-14">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-08-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-24">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-23">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-05">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="17368" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERTROPHIC MYOCARDIOPATHY</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy</ElementValue>
                <XRef ID="HP:0001639" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005045" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20518" />
                <XRef ID="20518" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="217569" DB="Orphanet" />
              <XRef ID="C0007194" DB="MedGen" />
              <XRef ID="D002312" DB="MeSH" />
              <XRef ID="MONDO:0005045" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001639" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="69132" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="57186" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy</ElementValue>
                <XRef ID="MONDO:0859168" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFM12</ElementValue>
                <XRef Type="MIM" ID="619424" DB="OMIM" />
              </Symbol>
              <XRef ID="C5561937" DB="MedGen" />
              <XRef ID="MONDO:0859168" DB="MONDO" />
              <XRef Type="MIM" ID="619424" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3886" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="677" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy 10</ElementValue>
                <XRef ID="MONDO:0012112" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypertrophic cardiomyopathy 10</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYL2-Related Familial Hypertrophic Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="608758" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMH10</ElementValue>
                <XRef Type="MIM" ID="608758" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301725</ID>
                <ID Source="BookShelf">NBK1768</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21267010</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C1834460" DB="MedGen" />
              <XRef ID="MONDO:0012112" DB="MONDO" />
              <XRef Type="MIM" ID="608758" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="408917" SubmissionDate="2018-05-01" DateLastUpdated="2018-05-05" DateCreated="2015-06-08">
        <ClinVarSubmissionID localKey="chr12:109833339del" localKeyIsSubmitted="1" submittedAssembly="NCBI36" />
        <ClinVarAccession Accession="SCV000055308" DateUpdated="2018-05-05" DateCreated="2015-06-08" Type="SCV" Version="2" SubmitterName="Biesecker Lab/Clinical Genomics Section, National Institutes of Health" OrgID="1160" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">yes</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="NCBI36" Chr="12" alternateAllele="-" referenceAllele="G" start="109833339" stop="109833339" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.3:c.426del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cardiomyopathy, hypertrophic</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>The study set was not selected for affection status in relation to arrhythmia or cardiomyopathy. Pathogenicity categories were based on literature curation. See Pubmed ID:25741868 for details.</Comment>
        <Comment>Medical sequencing</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB3964774</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1438841" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-04-16">
        <ClinVarSubmissionID localKey="a654855|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000740150" DateUpdated="2024-05-01" DateCreated="2018-04-16" Type="SCV" Version="6" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23365102</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23861362</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28855170</ID>
          </Citation>
          <Comment>The c.431delC variant, located in coding exon 7 of the MYL2 gene, results from a deletion of one nucleotide at position 431, causing a translational frameshift with a predicted alternate stop codon (p.P144Lfs*3). This alteration occurs at the 3' terminus of theMYL2 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 13% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This alteration was reported in two siblings with infantile type I muscle fibre disease and cardiomyopathy, both with c.432delT in trans. The parents were each heterozygous for only one of the two alterations and did not show indications of cardiomyopathy (Weterman MA et al. Brain, 2013 Jan;136:282-93). This alteration has also been reported as a secondary cardiac variant in an exome cohort (Ng D et al. Circ Cardiovasc Genet, 2013 Aug;6:337-46). Although biallelic loss of function alterations in MYL2 have been associated with autosomal recessive MYL2-related myofibrillar myopathy with cardiomyopathy, haploinsufficiency for MYL2 has not been clearly established as a mechanism of disease for autosomal dominant MYL2-related cardiomyopathy. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.3:c.431delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3488859" SubmissionDate="2021-08-05" DateLastUpdated="2021-08-14" DateCreated="2021-08-14">
        <ClinVarSubmissionID localKey="160781.0007_MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY" title="MYL2, 1-BP DEL, 431C_MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY" />
        <ClinVarAccession Accession="SCV001774789" DateUpdated="2021-08-14" DateCreated="2021-08-14" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Italian brothers with infantile-onset myofibrillar myopathy-12 with cardiomyopathy (MFM12; 619424), Weterman et al. (2013) identified compound heterozygous frameshift mutations affecting adjacent nucleotides in the last exon of the MYL2 gene: c.431delC, causing Pro144LeufsTer2, and c.432delT (160781.0008), causing Asp145ThrfsTer2. The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Functional studies of the variants were not performed, but they were predicted to result in the production of C-terminally truncated proteins.</Attribute>
              <Citation>
                <ID Source="PubMed">23365102</ID>
              </Citation>
              <XRef DB="OMIM" ID="619424" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <Name>MYL2, 1-BP DEL, 431C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 431C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="160781.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4201216" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4910808|MedGen:C1834460" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002179962" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23365102</ID>
          </Citation>
          <Comment>In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 191580). This premature translational stop signal has been observed in individual(s) with autosomal recessive infantile type I muscle fibre disease and cardiomyopathy (PMID: 23365102). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Pro144Leufs*3) in the MYL2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 23 amino acid(s) of the MYL2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.111348951del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1834460" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3488859" TraitType="Disease" MappingType="Name" MappingValue="MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY" MappingRef="Preferred">
        <MedGen CUI="C5561937" Name="Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="408917" TraitType="Disease" MappingType="Name" MappingValue="Cardiomyopathy, hypertrophic" MappingRef="Preferred">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1438841" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4201216" TraitType="Disease" MappingType="XRef" MappingValue="C1834460" MappingRef="MedGen">
        <MedGen CUI="C1834460" Name="Hypertrophic cardiomyopathy 10" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

